Pheochromocytoma: An endocrine stress mimicking disorder

Annals of the New York Academy of Sciences

Volumn 1148, Issue , 2008, Pages 462-468

  Kantorovich, Vitaly ^a   Eisenhofer, Graeme ^b   Pacak, Karel ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenoceptors; Catecholamines; General adaptation syndrome; Glucocorticoids; Hypothalamic pituitary adrenocortical axis; Pheochromocytoma; Stress

Indexed keywords

CATECHOLAMINE;

CATECHOLAMINE RELEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE SEVERITY; EMOTIONAL DISORDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PHEOCHROMOCYTOMA; STRESS; SYMPTOMATOLOGY;

EID: 57649210169     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1410.081     Document Type: Conference Paper

References (38)

1. Eisenhofer, G., I.J. Kopin & D.S. Goldstein. 2004. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol. Rev. 56 : 331 349.
2. Cryer, P.E. 1993. Adrenaline: a physiological metabolic regulatory hormone in humans? Int. J. Obes. Relat. Metab. Disord. 17 (Suppl 3 S43 S46.
3. Goldstein, D.S. & I.J. Kopin. 2007. Evolution of concepts of stress. Stress 10 : 109 120.
4. Pacak, K., M. Palkovits, G. Yadid, et al. 1998. Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am. J. Physiol. 275 : R1247 R1255.
5. Goldstein, D.S. 2003. Catecholamines and stress. Endocrine Regul. 37 : 69 80.
6. Lenders, J.W., G. Eisenhofer, M. Mannelli & K. Pacak. 2005. Phaeochromocytoma. Lancet 366 : 665 675.
7. Dluhy, R.G., J.E. Lawrence & G.H. Williams. 2003. Pheochromocytoma. In Williams Textbook of Endocrinology, 10th ed. Philadelphia. Saunders.
8. Cannon, W.B. 1942. "Voodoo" death. Am. Anthropologist. 44 (new series 169 118.
9. Richter, C.P. 1957. On the phenomenon of sudden death in animal and man. Psychosomatic Med. 19 : 191 198.
10. Selye, H. 1958. The Chemical Prevention of Cardiac Necrosis. Ronald Press. New York, NY.
11. Koskelo, P., S.O. Punsar & W. Sipila. 1964. Subendocardial haemorrhage and ECG changes in intracranial bleeding. BMJ 1 : 1479 1483.
12. Connor, R.C.R. 1969. Myocardial damage secondary to brain lesions. Am. Heart J. 78 : 145 148.
13. Josué, O. 1907. Hypertrophie cardiaque cause par l'adrenaline and la toxine typhique. C. R. Soc. Biol. (Paris) 63 : 285 287.
14. Samuels, M.A. 2007. The brain-heart connection. Circulation 116 : 77 84.
15. Raab, W., E. Stark, W.H. MacMillan & W.R. Gigee. 1961. Sympathogenic origin and anti-adrenergic prevention of stress-induced myocardial lesions. Am. J. Cardiol. 8 : 203 211.
16. Wittstein, I.S., D.R. Thiemann, J.A. Lima, et al. 2005. Neurohumoral features of myocardial stunning due to sudden emotional stress. N. Engl. J. Med. 352 : 539 534.
17. Buchholz, S. & G. Rudan. 2007. Tako-tsubo syndrome on the rise: a review of the current literature. Postgrad. Med. J. 83 : 261 264.
18. Dabrowska, B., A. Dabrowski, P. Pruszczyk, et al. 1995. Heart rate variability in pheochromocytoma. Am. J. Cardiol. 76 : 1202 1204.
19. Gatzoulis, K.A., G. Tolis, Theopistou, et al. 1998. Cardiomyopathy due to a pheochromocytoma: a reversible entity. Acta Cardiol. 53 : 227 229.
20. Bravo, E.L. 1991. Pheochromocytoma: new concepts and future trends. Kidney Int. 40 : 544 556.
21. Liao, W.B., C.F. Liu, C.W. Chiang, et al. 2000. Cardiovascular manifestations of pheochromocytoma. Am. J. Emerg. Med. 18 : 622 625.
22. McManus, B.M., T.A. Fleury & W.C. Roberts. 1981. Fatal catecholamine crisis in pheochromocytoma: curable cause of cardiac arrest. Am. Heart J. 102 : 930 932.
23. Nanda, A.S., A. Feldman & C.S. Liang. 1995. Acute reversal of pheochromocytoma-induced catecholamine cardiomyopathy. Clin. Cardiol. 18 : 421 423.
24. Huddle, K.R., B. Kalliatakis & J. Skoularigis. 1996. Pheochromocytoma associated with clinical and echocardioagraphic features simulating hypertrophic obstructive cardiomyopathy. Chest 109 : 1394 1397.
25. Scott, I.U. & D.D. Gutterman. 1995. Pheochromocytoma with reversible focal cardiac dysfunction. Am. Heart J. 130 : 909 911.
26. Kline, I.K. 1961. Myocardial alterations associated with pheochromo-cytoma. Am. J. Pathol. 38 : 539 551.
27. Simon, M. & S.E. Downin. 1985. Coronary vasoconstriction and catecholamine cardiomyopathy. Am. Heart J. 109 : 297 304.
28. Sardesai, S.H., A.J. Mourant, Y. Sivathandon, et al. 1990. Pheochromocytoma and catecholamine-induced cardiomyopathy presenting as heart failure. Br. Heart J. 63 : 234 237.
29. Schuiki, E.R., R. Jenni, F.W. Amann, et al. 1993. A reversible form of apical left ventricular hypertrophy associated with pheochromocytoma. J. Am. Soc. Echocardiogr. 6 : 327 331.
30. Hamada, N., A. Akamatsu & T. Joh. 1993. A case of pheochromocytoma complicated with acute renal failure and cardiomyopathy. Jpn. J. Circ. 57 : 84 90.
31. Suga, K., K. Tsukamoto, K. Nishigauchi, et al. 1996. Iodine-123-MIBG imaging in pheochromocytoma with cardiomyopathy and pulmonary edema. J. Nucl. Med. 37 : 1361 1364.
32. Bravo, E., F. Fouad-Tarazi, G. Rossi, et al. 1990. A reevaluation of the hemodynamics of pheochromocytoma. Hypertension 15 : 1128 1131.
33. Snavely, M.D., M.G. Ziegler & P.A. Insel. 1985. Subtype-selective down-regulation of rat renal cortical alpha- and beta-adrenergic receptors by catecholamines. Endocrinology 117 : 2182 2189.
34. Tsujimoto, G., W.M. Manger & B.B. Hoffman. 1984. Desensitization of beta-adrenergic receptors by pheochromocytoma. Endocrinology 114 : 1272 1278.
35. Greenacre, J.K. & M.E. Conolly. 1978. Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: studies in vivo. Br. J. Clin. Pharmacol. 5 : 191 197.
36. Krause, M., D. Reinhardt & K. Kruse. 1988. Phaeochromocytoma without symptoms: desensitization of the alpha- and beta-adrenoceptors. Eur. J. Pediatr. 147 : 121 122.
37. Ratge, D. & H. Wisser. 1986. Alpha- and beta-adrenergic receptor activity in circulating blood cells of patients with phaeochromocytoma: effects of adrenalectomy. Acta Endocrinol. (Copenh.) 111 : 80 88.
38. Cases, A., M. Bono, J. Gaya, et al. 1995. Reversible decrease of surface beta 2-adrenoceptor number and response in lymphocytes of patients with pheochromocytoma. Clin. Exp. Hypertens. 17 : 537 549.